A Multi-Billion Dollar Market For CRISPR Therapies Is Possible

In a recent conversation with Nobel Prize winning CRISPR pioneer Jennifer Doudna, we explored the transformative potential of gene editing for medicine, agriculture, and society.

The power of CRISPR cannot be overstated. The first CRISPR therapy, approved by the Food and Drug Administration at the end of 2023, can effectively…

Continue Reading


News Source: www.forbes.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *